The diagnosis of early‐stage mycosis fungoides: Views held by experts and non‐experts in cutaneous lymphoma
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025-09 · 23 (9) · 1094-1102
DOI: 10.1111/ddg.15799 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 29.06.2025. Verfasst von Paula Beatty und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Tallaght University Hospital/Trinity College Dublin, Tallaght, Dublin, Ireland. Hauptthemen laut MEDLINE: Mycosis Fungoides, Skin Neoplasms, Attitude of Health Personnel. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and Objectives Mycosis fungoides (MF) accounts for the majority of cutaneous lymphomas (CL). There is a documented delay in the diagnosis of early‐stage MF. However, its timely diagnosis is paramount to avoid potentially harmful therapies and undue patient distress. The aim of this study was to examine and compare the views held by both specialists and non‐specialists in CL regarding the diagnosis of early‐stage MF, to identify clinical needs.
Methods
Two distinct questionnaires were distributed to physicians, who either have a potential or no special interest in CL (non‐specialists), or who have a special interest in CL (specialists) and who were identified by participation in the PROCLIPI (PROspective Cutaneous Lymphoma International Prognostic Index) study.
Results
Survey results were received from 382 participants, 86 specialists, and 296 non‐specialists. In total, 82% of respondents held the view that the diagnosis of early‐stage MF is delayed. The frequent misclassification of MF as a benign inflammatory dermatosis was identified as the most important contributing factor.
Conclusions
Non‐specialists assume that a delayed diagnosis impairs therapeutic efficacy and prognosis in MF, while specialists primarily suspect negative effects on patients’ health‐related quality of life. Our study reveals an unmet need to promote education and increase awareness among dermatologists regarding the impact of early‐stage MF on patient management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Dermatology, Tallaght University Hospital/Trinity College Dublin, Tallaght, Dublin, Ireland.
- Department of Dermatology, Medical University of Vienna, Vienna, Austria.
- Department of Dermatology and Venereology, University Hospital of St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria.
- Karl Landsteiner Institute of Dermatological Research, St. Pölten, Austria.
- Department of Dermatology, Centre for Rare Diseases, University Hospitals Birmingham, Birmingham, UK.
ORCID-Profile: Paula Beatty, Constanze Jonak
Zitieren
APA
Beatty, P., Molloy, K., Porkert, S., Foley, M. P., Tobin, A. M., Trautinger, F., Scarisbrick, J., & Jonak, C. (2025). The diagnosis of early‐stage mycosis fungoides: Views held by experts and non‐experts in cutaneous lymphoma. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 23(9), 1094-1102. https://doi.org/10.1111/ddg.15799
Vancouver
Beatty P, Molloy K, Porkert S, Foley MP, Tobin AM, Trautinger F, et al. The diagnosis of early‐stage mycosis fungoides: Views held by experts and non‐experts in cutaneous lymphoma. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025;23(9):1094-1102. doi:10.1111/ddg.15799
BibTeX
@article{Beatty2025,
author = {Beatty, Paula and Molloy, Kevin and Porkert, Stefanie and Foley, Megan Power and Tobin, Anne-Marie and Trautinger, Franz and Scarisbrick, Julia and Jonak, Constanze},
title = {The diagnosis of early‐stage mycosis fungoides: Views held by experts and non‐experts in cutaneous lymphoma},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2025},
volume = {23},
number = {9},
pages = {1094--1102},
doi = {10.1111/ddg.15799}
}
EUVIMED